Liu Dongfang

CHIEF MEDICAL OFFICER

Liu Dongfang has filed 5 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Apr 21, 2026.

On the most recent filing, Liu Dongfang is listed as CHIEF MEDICAL OFFICER at Nuvation Bio Inc. Inside the rolling window, Liu Dongfang reported no open-market purchases and 7 open-market sales totaling $1.9M in NUVB. The largest disclosed transaction in the window is a sale of 150,000 NUVB shares on Dec 1, 2025, worth $1.2M.

Companies traded

Other insiders at NUVB

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.9M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
NUVBSale$251KApr 21SEC ↗
NUVBSale$1.2MDec 3SEC ↗
NUVBSale$75KNov 26SEC ↗
NUVBSale$80KNov 26SEC ↗
NUVBSale$140KNov 24SEC ↗
NUVBSale$71KNov 19SEC ↗
NUVBSale$77KNov 19SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Liu Dongfang made?

Liu Dongfang has filed 5 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.

Which companies does Liu Dongfang trade?

Liu Dongfang has filed SEC Form 4 disclosures for 1 company, including NUVB.

When was Liu Dongfang's most recent SEC Form 4 filing?

Liu Dongfang's most recent SEC Form 4 filing on Tracefour is dated Apr 21, 2026.

What is Liu Dongfang's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Liu Dongfang is listed as CHIEF MEDICAL OFFICER.

What is Liu Dongfang's total buy and sell value in the current window?

Inside the rolling retention window, Liu Dongfang bought $0 and sold $1.9M based on SEC Form 4 filings.

What was Liu Dongfang's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 150,000 NUVB shares on 2025-12-01, worth $1.2M, per SEC Form 4 filings.